Title: Antibody:CD47 ratio regulates macrophage phagocytosis through competitive receptor phosphorylation

Journal Article · · Cell Reports
 [1];  [2]; ORCiD logo [3];  [4];  [5]; ORCiD logo [6]
  1. University of California, Berkeley, CA (United States); University of California, San Francisco, CA (United States)
  2. University of California, Berkeley, CA (United States)
  3. University of California, Berkeley, CA (United States); Carleton University, Ottawa, ON (Canada)
  4. Aduro Biotech Europe, Oss (Netherlands)
  5. Aduro Biotech Inc., Emeryville, CA (United States)
  6. University of California, Berkeley, CA (United States); University of California, San Francisco, CA (United States); Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States); Chan Zuckerberg Biohub, San Francisco, CA (United States)

Cancer immunotherapies often modulate macrophage effector function by introducing either targeting antibodies that activate Fcγ receptors (FcγRs) or blocking antibodies that disrupt inhibitory SIRPα-CD47 engagement. However, how these competing signals are integrated is poorly understood, raising questions about how to effectively titrate immune responses. Here, we find that macrophage phagocytic decisions are regulated by the ratio of activating ligand to inhibitory ligand over a broad range of absolute molecular densities. Using both endogenous and chimeric receptors, we show that activating:inhibitory ligand ratios of at least 10:1 are required to promote phagocytosis of model antibody-opsonized CD47-inhibited targets and that lowering that ratio reduces FcγR phosphorylation because of inhibitory phosphatases recruited to CD47-bound SIRPα. We demonstrate that ratiometric signaling is critical for phagocytosis of tumor cells and can be modified by blocking SIRPα, indicating that balancing targeting and blocking antibodies may be important for controlling macrophage phagocytosis in cancer immunotherapy.

Research Organization:
Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
Sponsoring Organization:
National Institutes of Health (NIH); National Science Foundation (NSF); USDOE
Grant/Contract Number:
AC02-05CH11231
OSTI ID:
2470754
Journal Information:
Cell Reports, Journal Name: Cell Reports Journal Issue: 8 Vol. 36; ISSN 2211-1247
Publisher:
ElsevierCopyright Statement
Country of Publication:
United States
Language:
English

References (66)

Structural basis for syk tyrosine kinase ubiquity in signal transduction pathways revealed by the crystal structure of its regulatory SH2 domains bound to a dually phosphorylated ITAM peptide journal August 1998
Associations between the uptake of 111In-DTPA-trastuzumab, HER2 density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts journal August 2008
The ‘Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling journal June 2003
Sequential Involvement of Lck and SHP-1 with MHC-Recognizing Receptors on NK Cells Inhibits FcR-Initiated Tyrosine Kinase Activation journal December 1996
Blocking “don't eat me” signal of CD47-SIRPα in hematological malignancies, an in-depth review journal November 2018
Cell adhesion molecules and actin cytoskeleton at immune synapses and kinapses journal October 2007
CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells journal July 2009
Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma journal September 2010
Integrins Form an Expanding Diffusional Barrier that Coordinates Phagocytosis journal January 2016
Size-Dependent Segregation Controls Macrophage Phagocytosis of Antibody-Opsonized Targets journal June 2018
Requirements for Vav Guanine Nucleotide Exchange Factors and Rho GTPases in FcγR- and Complement-Mediated Phagocytosis journal March 2006
Dendritic Cells but Not Macrophages Sense Tumor Mitochondrial DNA for Cross-priming through Signal Regulatory Protein α Signaling journal August 2017
CD47 Ligation Repositions the Inhibitory Receptor SIRPA to Suppress Integrin Activation and Phagocytosis journal August 2020
High-Throughput Phosphotyrosine Profiling Using SH2 Domains journal June 2007
The balancing act: Inhibitory Ly49 regulate NKG2D-mediated NK cell functions journal June 2006
Substrate Specificity of Protein Tyrosine Phosphatases 1B, RPTPα, SHP-1, and SHP-2 journal March 2011
Diverse Levels of Sequence Selectivity and Catalytic Efficiency of Protein-Tyrosine Phosphatases journal January 2014
SYNZIP Protein Interaction Toolbox: in Vitro and in Vivo Specifications of Heterospecific Coiled-Coil Interaction Domains journal February 2012
A family of proteins that inhibit signalling through tyrosine kinase receptors journal March 1997
The kinetic-segregation model: TCR triggering and beyond journal July 2006
Fiji: an open-source platform for biological-image analysis journal June 2012
Elucidating membrane structure and protein behavior using giant plasma membrane vesicles journal May 2012
Phagocytosis checkpoints as new targets for cancer immunotherapy journal August 2019
Macrophage phagocytosis assay with reconstituted target particles journal June 2020
TrackNTrace: A simple and extendable open-source framework for developing single-molecule localization and tracking algorithms journal November 2016
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors journal March 2012
A Novel Phosphotyrosine Motif with a Critical Amino Acid at Position −2 for the SH2 Domain-mediated Activation of the Tyrosine Phosphatase SHP-1 journal May 1997
High Expression of Inhibitory Receptor SHPS-1 and Its Association with Protein-tyrosine Phosphatase SHP-1 in Macrophages journal August 1998
Structure of Signal-regulatory Protein α journal September 2009
Crystal Structure of Fcγ Receptor I and Its Implication in High Affinity γ-Immunoglobulin Binding journal September 2011
Effective Dephosphorylation of Src Substrates by SHP-1 journal March 2004
Affinity and Kinetic Analysis of Fcγ Receptor IIIa (CD16a) Binding to IgG Ligands journal March 2007
Molecular Mechanism of the Syk Activation Switch journal September 2008
Multimolecular Analysis of Stable Immunological Synapses Reveals Sustained Recruitment and Sequential Assembly of Signaling Clusters journal September 2013
Inhibition of “self” engulfment through deactivation of myosin-II at the phagocytic synapse between human cells journal March 2008
A Critical Role for Syk in Signal Transduction and Phagocytosis Mediated by Fcγ Receptors on Macrophages journal October 1997
Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2 journal May 2012
Disruption of SIRPα signaling in macrophages eliminates human acute myeloid leukemia stem cells in xenografts journal September 2012
Design of novel FN3 domains with high stability by a consensus sequence approach journal January 2012
Non‐catalytic tyrosine‐phosphorylated receptors journal October 2012
Multiple roles of Lyn kinase in myeloid cell signaling and function journal March 2009
Discovery of a Novel Shp2 Protein Tyrosine Phosphatase Inhibitor journal May 2006
Identification of Two Distinct Mechanisms of Phagocytosis Controlled by Different Rho GTPases journal November 1998
Role of CD47 as a Marker of Self on Red Blood Cells journal June 2000
The Syk Protein Tyrosine Kinase Is Essential for Fcγ Receptor Signaling in Macrophages and Neutrophils journal July 1998
Vav1 Dephosphorylation by the Tyrosine Phosphatase SHP-1 as a Mechanism for Inhibition of Cellular Cytotoxicity journal September 2003
The Interaction Between Signal Regulatory Protein Alpha (SIRP α ) and CD47: Structure, Function, and Therapeutic Target journal March 2014
Human Epidermal Growth Factor Receptor 2 (HER2) in Cancers: Overexpression and Therapeutic Implications journal September 2014
Cellular Cytotoxicity of Next-Generation CD20 Monoclonal Antibodies journal October 2018
CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer journal June 2016
Anti-SIRPα antibodies as a potential new tool for cancer immunotherapy journal January 2017
Evidence that the red cell skeleton protein 4.2 interacts with the Rh membrane complex member CD47 journal January 2003
SHP-1 regulates Fcγ receptor–mediated phagocytosis and the activation of RAC journal September 2002
CellProfiler: image analysis software for identifying and quantifying cell phenotypes journal October 2006
The effect of phosphatases SHP-1 and SHIP-1 on signaling by the ITIM- and ITAM-containing Fcγ receptors FcγRIIB and FcγRIIA journal June 2003
A WAVE2-Abi1 complex mediates CSF-1-induced F-actin-rich membrane protrusions and migration in macrophages journal November 2005
Matched Sizes of Activating and Inhibitory Receptor/Ligand Pairs Are Required for Optimal Signal Integration by Human Natural Killer Cells journal November 2010
Developmental Neuronal Death in Hippocampus Requires the Microglial CD11b Integrin and DAP12 Immunoreceptor journal August 2008
Trastuzumab journal January 2002
The diverse functions of Src family kinases in macrophages journal January 2008
CD38 Antibodies in Multiple Myeloma: Mechanisms of Action and Modes of Resistance journal September 2018
A Computational Model for Early Events in B Cell Antigen Receptor Signaling: Analysis of the Roles of Lyn and Fyn journal June 2012
Human Lymphocytes Interact Directly with CD47 through a Novel Member of the Signal Regulatory Protein (SIRP) Family journal August 2004
Negative Regulation of Phagocytosis in Macrophages by the CD47-SHPS-1 System journal February 2005
LFA-1-Mediated T Cell Costimulation through Increased Localization of TCR/Class II Complexes to the Central Supramolecular Activation Cluster and Exclusion of CD45 from the Immunological Synapse journal August 2007
Antibody-dependent cellular phagocytosis is responsible for efficacy of anti-CD20 monoclonal antibody therapy in chronic lymphocytic leukemia journal May 2018